Comoglio Research Group

Official Twitter account of the Comoglio Research Group. Located at IFOM Milan.

Passionate and driven researchers.

[Dogus Altintas @AltintasDogus]

Very happy to publish the molecular mechanism of the rebound effect to MET-targeted therapy in cancer! @IFOMresearch @AIRC_it @Fondaz_Veronesi @Comogliogroup

[Dogus Altintas @AltintasDogus]

A new MET functional domain @ResearchGate: https://t.co/Vo5TkMnuFw

[Dogus Altintas @AltintasDogus]

Did you think that MET oncogene was only a tyrosine kinase? Check out our new research paper revealing an unsuspected enzymatic activity of the receptor. Online soon at the special issue of IJMS... @IFOMresearch @AIRC_it @fpoirccs

[LifeScienceAlliance @LSAjournal]

Mutated MET∆14 kinase is not constitutively active but requires HGF. The response to the ligand is stronger and long-lasting, protecting cancer cells from apoptosis and driving invasive growth. @IFOMresearch @AltintasDogus @Comogliogroup @airc_it

https://t.co/hASW2cI30T

[Dogus Altintas @AltintasDogus]

My first last-author paper.

[World of Statistics @stats_feed]

Share of electricity from nuclear ☢️:

🇫🇷 France: 69%
🇺🇦 Ukraine: 52%
🇧🇪 Belgium: 51%
🇨🇿 Czechia: 36%
🇨🇭 Switzerland: 34%
🇫🇮 Finland: 34%
🇸🇪 Sweden: 31%
🇪🇸 Spain: 21%
🇷🇺 Russia: 20%
🇺🇸 USA: 19%
🇬🇧 UK: 15%
🇩🇪 Germany: 12%
🇳🇱 Netherlands: 3%
🇦🇹 Austria: 0%

[Comoglio Research Group @Comogliogroup]

@Comogliogroup The official account of Prof. Paolo Comoglio lab